KIORA PHARMACEUTICALS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

KPRX

organization

SIC: 2834

Also known as: Kiora Pharmaceuticals, Inc.

SEC Insider

$45.9M

584 transactions

Summary

KIORA PHARMACEUTICALS INC (KPRX) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $19.9MSales: $15.6M31 insiders

Date	Insider	Type	Value
2026-04-01	Strem Brian M.(President and CEO)	F	$4K
2026-04-01	Daniels Eric Joseph(Chief Development Officer)	F	$2K
2026-04-01	Tosca Melissa(CFO)	F	$2K
2026-03-03	Strem Brian M.(President and CEO)	F	$480.76
2026-03-03	Daniels Eric Joseph(Chief Development Officer)	F	$480.76
2026-06-10	TYLE PRAVEEN	A	$0
2026-06-10	Walters-Hoffert Lisa	A	$0
2026-06-10	Hollander David	A	$0
2026-06-10	Shapiro Aron	A	$0
2026-06-10	Stengone Carmine N.	A	$0
2026-06-10	Parsons Erin	A	$0
2026-03-06	Tosca Melissa(CFO)	A	$0
2026-03-06	Tosca Melissa(CFO)	A	$0
2026-03-06	Strem Brian M.(President and CEO)	A	$0
2026-03-06	Strem Brian M.(President and CEO)	A	$0
2026-03-06	Daniels Eric Joseph(Chief Development Officer)	A	$0
2026-03-06	Daniels Eric Joseph(Chief Development Officer)	A	$0
2025-04-01	Walters-Hoffert Lisa	A	$0
2025-04-01	Stengone Carmine N.	A	$0
2025-04-01	TYLE PRAVEEN	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

KIORA PHARMACEUTICALS INC — Contributions, Lobbying & Contracts | Poliscope